Policies and Guidance Papers

CL-BP-001 Blood Component Utilization in Adults and Pediatrics

• CL-BP-010 Irradiated Blood Component Administration
• CL-BP-045, IWK CL-B-640 C1 Esterase Policy
• CL-BP-025, IWK-629 Use of Intravenous and Subcutaneous Immunoglobulins (IVIG/SCIG)
  • Atlantic Clinical Indications and Criteria for Intravenous and Subcutaneous Immunoglobulin (IVIG-SCIG)
  • Atlantic Guidelines for SCIG Home Administration Programs
• Utilization Best Practices for Group O Rh Negative Red Blood Cells

Prothrombin Complex Concentrates

• NS Guideline for the Management of Patients on Vitamin K Antagonists or Direct Oral Anticoagulants Utilizing Prothrombin Complex Concentrates

Rh Testing

• Guideline for Rh Testing in Nova Scotia
• Laboratory Pre-Natal RhD Typing Flowchart
• Laboratory Rh Typing Flowchart – All Samples Except Pre-Natal

Massive Transfusion

• Massive Hemorrhage Guideline

Blood Emergency Preparedness

• The Provincial Blood Contingency Plan
• National Plan for the Management of Shortages of labile Blood Components
• Emergency framework for rationing of blood for massively bleeding patients during a red phase of a blood shortage

Recipient Recall Notice

• NAC Recommendations for the Notification of Recipients of a Blood Component Recall